Yale University

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

TitleRisk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Publication TypeJournal Article
Year of Publication2012
AuthorsGandhi, N. R., J. R. Andrews, J. C. M. Brust, R. Montreuil, D. Weissman, M. Heo, A. P. Moll, G. H. Friedland, and N. S. Shah
JournalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Volume16
Issue1
Pagination90-7
Date Published2012 Jan
ISSN1815-7920
KeywordsAdult, AIDS-Related Opportunistic Infections, Anti-Retroviral Agents, Antitubercular Agents, CD4 Lymphocyte Count, Coinfection, Drug Resistance, Multiple, Bacterial, Extensively Drug-Resistant Tuberculosis, Female, HIV Infections, Humans, Male, Markov Chains, Monte Carlo Method, Prevalence, Prognosis, Proportional Hazards Models, Retrospective Studies, Risk Assessment, Risk Factors, South Africa, Survival Analysis, Time Factors, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary
AbstractRecent studies suggest that the prevalence of drug-resistant tuberculosis (TB) in sub-Saharan Africa may be rising. This is of concern, as human immunodeficiency virus (HIV) co-infection in multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB has been associated with exceedingly high mortality rates.
DOI10.1097/QAI.0b013e3181fbc94f
Alternate JournalInt. J. Tuberc. Lung Dis.

External Links